These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9449391)
1. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Palatini P; Mormino P; Santonastaso M; Mos L; Dal Follo M; Zanata G; Pessina AC Hypertension; 1998 Jan; 31(1):57-63. PubMed ID: 9449391 [TBL] [Abstract][Full Text] [Related]
2. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Liu JE; Roman MJ; Pini R; Schwartz JE; Pickering TG; Devereux RB Ann Intern Med; 1999 Oct; 131(8):564-72. PubMed ID: 10523216 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Weber MA; Neutel JM; Smith DH; Graettinger WF Circulation; 1994 Nov; 90(5):2291-8. PubMed ID: 7955186 [TBL] [Abstract][Full Text] [Related]
4. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Björklund K; Lind L; Vessby B; Andrén B; Lithell H Circulation; 2002 Jul; 106(1):63-8. PubMed ID: 12093771 [TBL] [Abstract][Full Text] [Related]
5. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. Páll D; Juhász M; Lengyel S; Molnár C; Paragh G; Fülesdi B; Katona E J Hypertens; 2010 Oct; 28(10):2139-44. PubMed ID: 20616755 [TBL] [Abstract][Full Text] [Related]
6. White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. Høegholm A; Kristensen KS; Bang LE; Nielsen JW J Hum Hypertens; 1998 Jul; 12(7):433-9. PubMed ID: 9702928 [TBL] [Abstract][Full Text] [Related]
7. Endothelial function in sustained and white coat hypertension. Pierdomenico SD; Cipollone F; Lapenna D; Bucci A; Cuccurullo F; Mezzetti A Am J Hypertens; 2002 Nov; 15(11):946-52. PubMed ID: 12441213 [TBL] [Abstract][Full Text] [Related]
8. White-coat hypertension and cardiac organ damage in elderly subjects. Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402 [TBL] [Abstract][Full Text] [Related]
9. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Cavallini MC; Roman MJ; Pickering TG; Schwartz JE; Pini R; Devereux RB Hypertension; 1995 Sep; 26(3):413-9. PubMed ID: 7649575 [TBL] [Abstract][Full Text] [Related]
10. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Puato M; Palatini P; Zanardo M; Dorigatti F; Tirrito C; Rattazzi M; Pauletto P Hypertension; 2008 May; 51(5):1300-5. PubMed ID: 18378860 [TBL] [Abstract][Full Text] [Related]
11. Target organ status and serum lipids in patients with white coat hypertension. Pierdomenico SD; Lapenna D; Guglielmi MD; Antidormi T; Schiavone C; Cuccurullo F; Mezzetti A Hypertension; 1995 Nov; 26(5):801-7. PubMed ID: 7591021 [TBL] [Abstract][Full Text] [Related]
12. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. Palatini P; Dorigatti F; Roman E; Giovinazzo P; Piccolo D; De Venuto G; Mattarei M; Cozzutti E; Gregori S; Mormino P; Pessina AC J Hypertens; 1998 Jul; 16(7):977-84. PubMed ID: 9794738 [TBL] [Abstract][Full Text] [Related]
13. Masked hypertension and target organ damage in treated hypertensive patients. Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. Pierdomenico SD; Costantini F; Bucci A; De Cesare D; Cuccurullo F; Mezzetti A Hypertension; 1998 Feb; 31(2):621-6. PubMed ID: 9461231 [TBL] [Abstract][Full Text] [Related]
16. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
17. [Cardiac and vascular morphology in patients with "white-coat hypertension": echocardiographic and ultrasonographic study]. Cuspidi C; Marabini M; Lonati L; Sampieri L; Pontiggia G; Pelizzoli S; Leonetti G G Ital Cardiol; 1995 Dec; 25(12):1581-7. PubMed ID: 8707006 [TBL] [Abstract][Full Text] [Related]
18. 'White coat' hypertension in children. Hornsby JL; Mongan PF; Taylor AT; Treiber FA J Fam Pract; 1991 Dec; 33(6):617-23. PubMed ID: 1744607 [TBL] [Abstract][Full Text] [Related]
19. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
20. Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. Palatini P; Penzo M; Canali C; Dorigatti F; Pessina AC Am J Med; 1997 Sep; 103(3):208-16. PubMed ID: 9316553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]